Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Keiko Azuma, Ryo Asaoka, Aya Matsuda, Jihee Lee, Kimiko Shimizu, Hiroko Inui, Hiroshi Murata, Asako Ogawa, Motoshi Yamamoto, Tatsuya Inoue & Ryo Obata. (2018) Two-year outcome of treat-and-extend aflibercept after ranibizumab in age-related macular degeneration and polypoidal choroidal vasculopathy patients. Clinical Ophthalmology 12, pages 1589-1597.
Read now
Read now
Toshiaki Hirakata, Kaoru Fujinami, Ken Watanabe, Mariko Sasaki, Toru Noda & Kunihiko Akiyama. (2016) One-year outcome of intravitreal aflibercept injection for age-related macular degeneration resistant to ranibizumab: rapid morphologic recovery and subsequent visual improvement. Clinical Ophthalmology 10, pages 969-977.
Read now
Read now
Chandrakumar Balaratnasingam, Elona Dhrami-Gavazi, Jesse T McCann, Quraish Ghadiali & K Bailey Freund. (2015) Aflibercept: a review of its use in the treatment of choroidal neovascularization due to age-related macular degeneration. Clinical Ophthalmology 9, pages 2355-2371.
Read now
Read now
Articles from other publishers (19)
JayU Sheth, Raja Narayanan, Giridhar Anantharaman, Muna Bhende, Aniruddha Agarwal, Shobhit Chawla & Anand Rajendran. (2022) Updated guidelines for the management of polypoidal choroidal vasculopathy: Recommendations from the Indian Polypoidal Choroidal Vasculopathy Panel and the Vitreoretinal Society of India. Indian Journal of Ophthalmology 70:8, pages 3102.
Crossref
Crossref
V. G. Likhvantseva, V. N. Trubilin, S. G. Kapkova & A. S. Gevorgyan. (2021) To the Question of Terminology, Expert Criteria for Evaluating the Effectiveness of Antiangiogenic Therapy and the Prevalence of Refractory Forms of Neovascular Age-Related Macular Degeneration. Review. Ophthalmology in Russia 18:3, pages 389-398.
Crossref
Crossref
Jae Hui Kim, Jong Woo Kim, Chul Gu Kim & Dong Won Lee. (2020) Long-term switching between ranibizumab and aflibercept in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Graefe's Archive for Clinical and Experimental Ophthalmology 258:8, pages 1677-1685.
Crossref
Crossref
Adrian H. C. Koh. 2020. Choroidal Neovascularization. Choroidal Neovascularization
217
236
.
Sang Eun Lee, Jun Won Jang, Se Woong Kang, Kyu Hyung Park, Dong Won Lee, Jae Hui Kim & KunHo Bae. (2019) Intravitreal aflibercept for active polypoidal choroidal vasculopathy without active polyps. Scientific Reports 9:1.
Crossref
Crossref
Atul Kumar, Devesh Kumawat, Dheepak Sundar M, Meghal Gagrani, Barkha Gupta, Prakhyat Roop, Nasiq Hasan, Anu Sharma & Rohan Chawla. (2019) Polypoidal choroidal vasculopathy: a comprehensive clinical update. Therapeutic Advances in Ophthalmology 11, pages 251584141983115.
Crossref
Crossref
Tarek Alasil, Nelida Munoz, Pearse A. Keane, Adnan Tufail, Patrick A. Coady, Eduardo Novais, Talisa E. de Carlo, Caroline R. Baumal, Nadia K. Waheed, Jay S. Duker & Ron A. Adelman. (2017) Characteristics and racial variations of polypoidal choroidal vasculopathy in tertiary centers in the United States and United Kingdom. International Journal of Retina and Vitreous 3:1.
Crossref
Crossref
James G. Wong & Katherine Yu Qian. (2017) Long-Term Follow-Up of Polypoidal Choroidal Vasculopathy Secondary to Angioid Streaks Treated by Intravitreal Aflibercept and Ranibizumab. Case Reports in Ophthalmology 8:1, pages 221-231.
Crossref
Crossref
Naoya Yoshihara, Hiroto Terasaki, Makoto Shirasawa, Hiroki Kawano, Shozo Sonoda, Munekazu Yamaguchi, Teruto Hashiguchi, Toshio Hisatomi, Tatsuro Ishibashi & Taiji Sakamoto. (2017) PERMEABILITY AND ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR EFFECTS OF BEVACIZUMAB, RANIBIZUMAB, AND AFLIBERCEPT IN POLARIZED RETINAL PIGMENT EPITHELIAL LAYER IN VITRO. Retina 37:1, pages 179-190.
Crossref
Crossref
Geraldine R. Slean, Kornwipa Hemarat, Rahul N. Khurana & Jay M. Stewart. (2016) Conversion back to bevacizumab or ranibizumab for recurrent neovascular activity with aflibercept in age-related macular degeneration: a case series. International Journal of Retina and Vitreous 2:1.
Crossref
Crossref
Jinfeng Qu, Yong Cheng, Xiaoxin Li, Liyun Yu & Xiao Ke. (2016) EFFICACY OF INTRAVITREAL INJECTION OF CONBERCEPT IN POLYPOIDAL CHOROIDAL VASCULOPATHY. Retina 36:5, pages 926-937.
Crossref
Crossref
Raphaelle Despreaux, Salomon Y. Cohen, Oudy Semoun, Olivia Zambrowski, Camille Jung, Hassiba Oubraham & Eric H. Souied. (2015) Short-term results of switchback from aflibercept to ranibizumab in neovascular age-related macular degeneration in clinical practice. Graefe's Archive for Clinical and Experimental Ophthalmology 254:4, pages 639-644.
Crossref
Crossref
Aditya Sudhalkar, Divya Balakrishnan, Subhadra Jalali & Raja Narayanan. (2016) Systemic steroids as an aid to the management of Idiopathic Polypoidal Choroidal Vasculopathy (IPCV): A descriptive analysis. Saudi Journal of Ophthalmology 30:1, pages 14-19.
Crossref
Crossref
Alfredo García-Layana, Marta S. Figueroa, Javier Araiz, José M. Ruiz-Moreno, Francisco Gómez-Ulla, Luis Arias-Barquet & Nicholas Reiter. (2015) Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept. Drugs & Aging 32:10, pages 797-807.
Crossref
Crossref
Stefano Lazzeri, Guido Ripandelli, Maria Sole Sartini, Mariacristina Parravano, Monica Varano, Marco Nardi, Teresa Di Desidero, Paola Orlandi & Guido Bocci. (2015) Aflibercept administration in neovascular age-related macular degeneration refractory to previous anti-vascular endothelial growth factor drugs: a critical review and new possible approaches to move forward. Angiogenesis 18:4, pages 397-432.
Crossref
Crossref
Akiko Yamamoto, Annabelle A. Okada, Mariko Kano, Hideki Koizumi, Masaaki Saito, Ichiro Maruko, Tetsuju Sekiryu & Tomohiro Iida. (2015) One-Year Results of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy. Ophthalmology 122:9, pages 1866-1872.
Crossref
Crossref
Shigeyuki Ijiri & Kazuhisa Sugiyama. (2014) Short-term efficacy of intravitreal aflibercept for patients with treatment-naïve polypoidal choroidal vasculopathy. Graefe's Archive for Clinical and Experimental Ophthalmology 253:3, pages 351-357.
Crossref
Crossref
Mariana R. Thorell, Renata Portella Nunes, Gene W. Chen, Rishi R. Doshi, Jyoti Dugar, Mathew K. George, Brian T. Kim, Matthew D. Lowrance, Dimple Modi, Zayna Nahas, Giovanni Gregori, Zohar Yehoshua, William Feuer & Philip J. Rosenfeld. (2014) Response to Aflibercept After Frequent Re-treatment With Bevacizumab or Ranibizumab in Eyes With Neovascular AMD. Ophthalmic Surgery, Lasers and Imaging Retina 45:6, pages 526-533.
Crossref
Crossref
Izumi Yoshida, Tomoaki Shiba, Hikari Taniguchi, Mao Takahashi, Takeyoshi Murano, Nobuyuki Hiruta, Yuichi Hori, Hdieaki Bujo & Takatoshi Maeno. (2014) Evaluation of plasma vascular endothelial growth factor levels after intravitreal injection of ranibizumab and aflibercept for exudative age-related macular degeneration. Graefe's Archive for Clinical and Experimental Ophthalmology 252:9, pages 1483-1489.
Crossref
Crossref